95TH GENERAL ASSEMBLY
State of Illinois
2007 and 2008
HB0785


 
Introduced 2/7/2007, by Rep. Patricia R. Bellock
 
SYNOPSIS AS INTRODUCED:
 		














405 ILCS 5/2-110.1





405 ILCS 5/2-110.2 new










    Amends the Mental Health and Developmental Disabilities Code.  Changes the content of the quarterly report that a mental hospital or facility administering electro-convulsive therapy must submit to include: (i) whether the patient gave informed consent or received therapy without informed consent, was confined as subject to involuntary admission, or received the therapy on an emergency basis; (ii) the type and charge dose of electro-convulsive treatments used; (iii) the identity of the treating hospital; (iv) if no patients have been treated using electro-convulsive therapy during that quarter, a written statement to that effect; and (v) for the first quarter report of  each year, a copy of the informed consent used for electro-convulsive therapy, including any pamphlet or form information given to the patient on electro-convulsive therapy.  Requires the Department of Human Services to include in its annual report the names of all facilities that have failed to comply with the listed reporting requirements during the calendar year covered by the annual report.  Provide for the enforcement of the reporting requirements and civil penalties for failure to report. Effective immediately.
















LRB095 03729 LCT 23756 b

















FISCAL NOTE ACT MAY APPLY
















 


 


A BILL FOR









 











HB0785

LRB095 03729 LCT 23756 b






1
    AN ACT concerning mental health.


 
2
    Be it enacted by the People of the State of Illinois,
 
3
represented in the General Assembly:


 
4
    Section 5. The Mental Health and Developmental 
5
Disabilities Code is amended  by changing Section 2-110.1 and  by 
6
adding Section 2-110.2 as follows:
 



7
    (405 ILCS 5/2-110.1)



8
    Sec. 2-110.1. Reports. 

9
    (a) A mental hospital or facility at which 
10
electro-convulsive therapy
is administered shall submit to the 
11
Department quarterly reports
relating to the administration of 
12
the therapy for the purposes of reducing
morbidity or mortality 
13
and improving patient care.

14
    (b) A report shall provide the following information for 
15
each patient that received electro-convulsive therapy,
state 
16
the following for each quarter:


17
        (1) Whether the patient gave informed consent or 
18
    received therapy without informed consent pursuant to 
19
    Section 2-107 of this Code, was confined as subject to 
20
    involuntary admission, or received the therapy on an 
21
    emergency basis pursuant to subsection (d) of Section 2-107 
22
    of this Code.
The number of persons who received the 
23
    therapy, including:


 


 






HB0785
- 2 -
LRB095 03729 LCT 23756 b




1
            (A) the number of persons who gave informed consent 
2
        to the therapy;


3
            (B) the number of persons confined as subject to 
4
        involuntary admission
who gave informed consent to the 
5
        therapy;


6
            (C) the number of persons who received the therapy 
7
        without
informed consent pursuant to Section 2-107.1; 
8
        and



9
            (D) the number of persons who received the therapy 
10
        on an
emergency basis pursuant to subsection (d) of 
11
        Section 2-107.1.


12
        (2) The age, sex, and race of the patient
recipients of 
13
    the therapy.


14
        (3) The source of the treatment payment.


15
        (4) The average number, type (bilateral pulse, 
16
    unilateral pulse, and sine wave), and  charge dose of 
17
    electro-convulsive treatments administered for
each 
18
    complete series of treatments noting changes of type or 
19
    charge administered over course of treatment, but not 
20
    including maintenance treatments.


21
        (5) The average number of maintenance 
22
    electro-convulsive treatments
administered per month. The 
23
    maintenance treatments reports shall include the type, 
24
    charge dose, and number of treatments and shall indicate 
25
    whether it is the same as the original treatment type and 
26
    charge dose.



 


 






HB0785
- 3 -
LRB095 03729 LCT 23756 b




1
        (6) Any significant adverse reactions to the treatment 
2
    as defined by rule.


3
        (7) Autopsy findings if death followed within 14 days 
4
    after the date of
the administration of the therapy.

5
    (b-5) In addition to the reporting requirements set forth 
6
in subsection (b):

7
        (1) The identity of the treating hospital or facility 
8
    shall be disclosed in the quarterly and annual reports.
9
        (2) If no patients have been treated with 
10
    electro-convulsive therapy during the reported quarter, a 
11
    written statement to that effect shall be filed as the 
12
    quarterly report.
13
        (3) The report for the first quarter of each year shall 
14
    include a copy of the informed consent form used for 
15
    electro-convulsive therapy, including any pamphlet or form 
16
    information given to the patient on electro-convulsive 
17
    therapy.


18
        (4) The quarterly report shall include any
(8) Any

19
    other information required by the Department by rule.

20
    (c) The Department shall prepare and publish an annual 
21
written report
summarizing the information received under this 
22
Section. The Department shall include in the annual report the 
23
names of all facilities that have failed to comply with the 
24
reporting requirements of this Section during the calendar year 
25
covered by the annual report.
The report shall not contain any 
26
information that identifies or tends to
identify any facility, 
 


 






HB0785
- 4 -
LRB095 03729 LCT 23756 b




1
physician, health care provider, or patient.

2
    (d) The Department may collect data referred to in this 
3
Section electronically or in writing.

4
(Source: P.A. 90-538, eff. 12-1-97.)

 
5
    (405 ILCS 5/2-110.2  new)
6
    Sec. 2-110.2. Enforcement of reporting requirements. A 
7
facility  or physician that fails to submit the completed 
8
reports containing the information provided by Section 2-110.1 
9
of this Code  within 15 days following the close of a quarter 
10
shall be sent a written notice of noncompliance by the 
11
Department. The facility or physician has 15 days following 
12
receipt of the  written notice to comply with the reporting 
13
requirements. If a facility or physician fails to comply with 
14
the reporting requirements within 15 days of receipt of  the 
15
notice, the Department may take any of the following actions:
16
        (1) The Department may assign a specified time period 
17
    for the facility or physician to comply with the reporting 
18
    requirements.
19
        (2) The facility's or physician's failure to comply may 
20
    be reported to the Department of Public Health and the 
21
    Department of Financial and Professional Regulation, which 
22
    may take appropriate  disciplinary actions including, but 
23
    not limited to, suspension of the facility's or physician's 
24
    license.
25
        (3) The Department may recommend revoking the 
 


 






HB0785
- 5 -
LRB095 03729 LCT 23756 b




1
    facility's  approval to receive Medicaid reimbursements for 
2
    administration of electro-convulsive therapy.
3
        (4) The Department may revoke any contract it has with 
4
    the facility to provide mental health services.
5
        (5) The Department may seek injunctive relief to bar 
6
    administration of electro-convulsive therapy.
7
        (6) The  facility or the physician may be subject to a 
8
    $1,000 civil penalty for each  violation of the reporting 
9
    requirements if the facility or physician is found to have 
10
    knowingly or intentionally failed to comply with the 
11
    reporting requirements.
12
    The State's Attorney or Attorney General may enforce the 
13
provisions of this Section.
 

14
    Section 99. Effective date. This Act takes effect upon 
15
becoming law.